Hologic — May 1, 2025 release
Fiscal 2025 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001140361-25-016906
Showing in the filing
Revenue Organic excluding COVID-19 % Increase (Decrease)
“0.3% to 1.6%”
Period
FY2025
Measure
Company-defined measure
Source
Guidance table
All guidance in this release · 22
Non-GAAP tax rate for FY2025
“approximately 19.25%”
Non-GAAP tax rate assumption for FY2025
“approximately 19.25%”
Diluted shares outstanding for FY2025
“approximately 228 million”
Diluted shares outstanding assumption for FY2025
“approximately 228 million”
Revenue for FY2025
“$4,050 - $4,100”
Revenue Reported % Increase (Decrease) for FY2025
“0.5% to 1.7%”
Revenue Constant Currency % Increase (Decrea… for FY2025
“0.8% to 2.1%”
Revenue Organic % Increase (Decrease) for FY2025
“(0.7%) to 0.5%”
Revenue Organic excluding COVID-19 % Increas… for FY2025
“0.3% to 1.6%”
GAAP EPS for FY2025
“$2.47 - $2.57”
GAAP EPS Reported % Increase (Decrease) for FY2025
“(25.6%) to (22.6%)”
Non-GAAP EPS for FY2025
“$4.15 - $4.25”
Non-GAAP EPS Reported % Increase (Decrease) for FY2025
“1.7% to 4.2%”
Revenue for Q3 FY2025
“$1,000 - $1,010”
Revenue Reported % Increase (Decrease) for Q3 FY2025
“(1.1%) to (0.1%)”
Revenue Constant Currency % Increase (Decrea… for Q3 FY2025
“(1.0%) to (0.0%)”
Revenue Organic % Increase (Decrease) for Q3 FY2025
“(3.5%) to (2.5%)”
Revenue Organic excluding COVID-19 % Increas… for Q3 FY2025
“(2.9%) to (1.8%)”
GAAP EPS for Q3 FY2025
“$0.85 - $0.88”
GAAP EPS Reported % Increase (Decrease) for Q3 FY2025
“3.7% to 7.3%”
Non-GAAP EPS for Q3 FY2025
“$1.04 - $1.07”
Non-GAAP EPS Reported % Increase (Decrease) for Q3 FY2025
“(1.9%) to 0.9%”
Exhibit 99.1 · the passage around this item
… earlier in the release
Current Guidance
Previous Guidance
Guidance $
Reported %
Increase
(Decrease)
Constant
Currency %
Increase
(Decrease)
Organic %
Increase
(Decrease)
Organic
excluding
COVID-19 %
Increase
(Decrease)
Guidance $
Fiscal 2025
Revenue
$4,050 - $4,100
0.5% to 1.7%
0.8% to 2.1%
(0.7%) to 0.5%
0.3% to 1.6%
$4,050-$4,100
GAAP EPS
$2.47 - $2.57
(25.6%) to (22.6%)
$3.51-$3.61
Non-GAAP EPS
$4.15 - $4.25
1.7% to 4.2%
$4.25-$4.35
Q3 2025
Revenue
$1,000 - $1,010
(1.1%) to (0.1%)
(1.0%) to (0.0%)
(3.5%) to (2.5%)
(2.9%) to (1.8%)
GAAP EPS
$0.85 - $0.88
3.7% to 7.3%
Non-GAAP EPS
$1.04 - $1.07
(1.9%) to 0.9%
3
Use of Non-GAAP Financial Measures
The Company has presented the following non-GAAP financial measures in this press release: constant currency revenues; organic revenues; organic revenues excluding
COVID-19; non-GAAP gross margin; non-GAAP operating expenses; non-GAAP operating margin; non-GAAP effective tax rate; non-GAAP net income; non-GAAP net income margin; non-GAAP EPS; adjusted EBITDA; adjusted net leverage ratio and adjusted ROIC.
Organic revenue fo
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.